Can the early reduction of tumour markers predict outcome in surgically treated sporadic medullary thyroid carcinoma?

Langenbecks Arch Surg. 2008 Sep;393(5):699-703. doi: 10.1007/s00423-008-0375-6. Epub 2008 Jul 15.

Abstract

Background and aims: Patients with sporadic medullary thyroid carcinoma (MTC) have a variable clinical course. Our aim was to analyse the reduction of tumour markers after thyroidectomy with meticulous dissection and relate it to clinical outcome.

Materials and methods: Twenty consecutive patients with palpable sporadic MTC underwent thyroidectomy with central and uni- or bilateral modified radical neck dissection; three were subjected to mediastinal dissection. Basal (b-) and stimulated (s-) calcitonin (CT) and carcinoembryonic antigen (CEA)-levels were measured before and 6-8 weeks after primary surgery, and the reduction of these tumour markers was determined.

Results: Median CT (b- and s-) were markedly reduced after surgery (98.5% and 99.1%, respectively), and CEA decreased 11 times. CT (b-) fell >99% in seven patients after surgery; in these and four additional patients, CT (s-) showed a similar reduction. During follow-up (median 52.5 months), two patients (stages IV B and C) died of MTC; they had <95% reduction of CT. Four patients (stage IV A) are alive with verified metastases. Eight patients (one stage III, seven stage IV A) are alive with hypercalcitoninemia. Five stages I-III patients and one stage IV A patient are disease-free.

Conclusions: Thyroidectomy and meticulous dissection caused a pronounced reduction of tumour markers. A postoperative reduction of CT (s-) >or=97% seems to be associated with less aggressive clinical course, while CEA had lower predictive value.

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor / blood*
  • Biopsy, Needle
  • Calcitonin / blood*
  • Carcinoembryonic Antigen / blood*
  • Carcinoma, Medullary / blood
  • Carcinoma, Medullary / pathology
  • Carcinoma, Medullary / surgery*
  • Female
  • Follow-Up Studies
  • Humans
  • Lymph Nodes / pathology
  • Lymphatic Metastasis / pathology
  • Male
  • Middle Aged
  • Neck Dissection*
  • Neoplasm Recurrence, Local / blood
  • Neoplasm Recurrence, Local / diagnosis
  • Neoplasm Staging
  • Neoplasm, Residual / blood
  • Neoplasm, Residual / diagnosis
  • Neoplasms, Multiple Primary / blood
  • Neoplasms, Multiple Primary / pathology
  • Neoplasms, Multiple Primary / surgery*
  • Postoperative Complications / blood*
  • Prognosis
  • Thyroid Gland / pathology
  • Thyroid Neoplasms / blood
  • Thyroid Neoplasms / pathology
  • Thyroid Neoplasms / surgery*
  • Thyroidectomy*

Substances

  • Biomarkers, Tumor
  • Carcinoembryonic Antigen
  • Calcitonin